Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Eli Lilly and Company
Age
18–79
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Have been treated with a stable dose of metformin for at least 3 months and have been treated with an optimally effective and stable dose of an sulfonylurea for at least 6 months prior to screening.
HbA1c value between 7.0% and 10.0%, inclusive.
Body mass index (BMI) between 20 and 45 kilograms/square meter (kg/m\^2), inclusive.
You may not be if
Known type 1 diabetes mellitus.
More than 1 episode of severe hypoglycemia within 6 months prior to screening.
Two or more emergency room visits or hospitalizations due to poor glucose control in the 6 months prior to screening.
Severe gastrointestinal disease that may significantly impact gastric emptying or motility or having undergone gastric bypass or gastric banding surgery.
Previous history or active diagnosis of pancreatitis.
Positive hepatitis B surface antigen or hepatitis C antibody.
Clinical signs or symptoms of liver disease, or hepatic aminotransferases (aminotransferase or alanine aminotransferase) greater than 2.0× upper limit of normal (ULN) or elevated alkaline phosphatase (greater than ULN) unrelated to bone metabolic disease.
Elevated total bilirubin level (greater than ULN), clinically suspicious signs/symptoms of cirrhosis or history of cirrhosis.
Current diagnosis, personal history of neuroendocrine tumors, family history of any type of multiple endocrine neoplasia (MEN), or Von Hippel-Lindau.
